Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Maybe I was wrong about the Hepalink licensing deal being limited to certain indications. The news release wasn't really clear.
From the license deal news release it reads "Hepalink will be responsible for all clinical and development costs in the Territories, including a patient population that will be included in Resverlogix's planned Phase 3 BETonMACE trial."
